Practicing medicine at the front lines of the genomic revolution

Archives of Internal Medicine

Volumn 165, Issue 16, 2005, Pages 1815-1817

  Rubinstein, Wendy S ^a   Roy, Hemant K ^b  

^a EVANSTON NORTHWESTERN HEALTHCARE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E4; COMPLEMENT FACTOR H; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA;

ALLELE; ALZHEIMER DISEASE; DISEASE COURSE; EDITORIAL; FAMILY HISTORY; GENE MUTATION; GENE TARGETING; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HEMOCHROMATOSIS; HEREDITY; HOMOZYGOTE; LABORATORY DIAGNOSIS; MEDICAL PRACTICE; MEDICAL RESEARCH; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REPRODUCIBILITY; RETINA MACULA AGE RELATED DEGENERATION; RISK ASSESSMENT; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CLINICAL MEDICINE; GENETICS; HUMAN GENOME PROJECT; HUMANS; MEDICINE; PHYSICIAN'S PRACTICE PATTERNS;

EID: 25144522612     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.165.16.1815     Document Type: Editorial

References (30)

1. Cavalli-Sforza LL. The Human Genome Diversity Project: past, present and future. Nat Rev Genet. 2005;6:333-340.
2. Mouchawar J, Hensley-Alford S, Laurion S, et al. Impact of direct-to-consumer advertising for hereditary breast cancer testing on genetic services at a managed care organization: a naturally-occurring experiment. Genet Med. 2005;7:191-197.
3. Tabor HK, Risch NJ, Myers RM. Opinion: candidate-gene approaches for studying complex genetic traits: practical considerations. Nat Rev Genet. 2002;3:391-397.
4. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K. A comprehensive review of genetic association studies. Genet Med. 2002;4:45-61.
5. Ioannidis JP, Ntzani EE, Trikalinos TA, Contopoulos-Ioannidis DG. Replication validity of genetic association studies. Nat Genet. 2001;29:306-309.
6. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst. 2004;96:434-442.
7. Hirschhorn JN, Altshuler D. Once and again - issues surrounding replication in genetic association studies. J Clin Endocrinol Metab. 2002;87:4438-4441.
8. Manolio T. Novel risk markers and clinical practice. N Engl J Med. 2003;349:1587-1589.
9. Altshuler D, Hirschhorn JN, Klannemark M, et al. The common PPARγ Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet. 2000;26:76-80.
10. Weinshilboum R. Inheritance and drug response. N Engl J Med. 2003;348:529-537.
11. Breitner JC, Wyse BW, Anthony JC, et al. APOE-ε4 count predicts age when prevalence of AD increases, then declines: the Cache County Study. Neurology. 1999;53:321-331.
12. Bird TD. Genetic factors in Alzheimer's disease. N Engl J Med. 2005;352:862-864.
13. Hsiung GY, Sadovnick AD, Feldman H. Apolipoprotein E ε4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging. CMAJ. 2004;171:863-867.
14. Tsuang D, Larson EB, Bowen J, et al. The utility of apolipoprotein E genotyping in the diagnosis of Alzheimer disease in a community-based case series. Arch Neurol. 1999;56:1489-1495.
15. Beutler E, Felitti VJ, Koziol JA, Ho NJ, Gelbart T. Penetrance of 845G→A (C282Y) HFE hereditary haemochromatosis mutation in the USA. Lancet. 2002;359:211-218.
16. Stickel F, Österreicher CH, Datz C, et al. Prediction of progression to cirrhosis by a glutathione S-transferase P1 polymorphism in subjects with hereditary hemochromatosis. Arch Intern Med. 2005;165:1835-1840.
17. Michaëlsson K, Melhus H, Ferm H, Ahlbom A, Pedersen NL. Genetic liability to fractures in the elderly. Arch Intern Med. 2005;165:1825-1830.
18. Billings PR, Carlson RJ, Carlson J, et al. Ready for genomic medicine? perspectives of health care decision makers. Arch Intern Med. 2005;165:1917-1919.
19. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat Rev Genet. 2005;6:95-108.
20. Klein RJ, Zeiss C, Chew EY, et al. Complement factor H polymorphism in age-related macular degeneration. Science. 2005;308:385-389.
21. Haines JL, Hauser MA, Schmidt S, et al. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308:419-421.
22. Edwards AO, Ritter R III, Abel KJ, Manning A, Panhuysen C, Farrer LA. Complement factor H polymorphism and age-related macular degeneration. Science. 2005;308:421-424.
23. Potter JD. Toward the Last Cohort. Cancer Epidemiol Biomarkers Prev. 2004;13:895-897.
24. Risch N, Merikangas K. The future of genetic studies of complex human diseases. Science. 1996;273:1516-1517.
25. Salanti G, Sanderson S, Higgins JP. Obstacles and opportunities in meta-analysis of genetic association studies. Genet Med. 2005;7:13-20.
26. Rocha JC, Cheng C, Liu W, et al. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood. 2005;105:4752-4758.
27. Chan AT, Tranah GJ, Giovannucci EL, Hunter DJ, Fuchs CS. Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma. J Natl Cancer Inst. 2005;97:457-460.
28. Guttmacher AE, Collins FS, Carmona RH. The family history - more important than ever. N Engl J Med. 2004;351:2333-2336.
29. Williams RR, Hunt SC, Heiss G, et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol. 2001;87:129-135.
30. US Surgeon General's Family History Initiative. US Department of Health and Human Services Web site. Available at: http://www.hhs.gov/familyhistory/. Accessed April 12, 2005.